Details of the Drug Formulations

General Information of Drug (ID: DMQJHR7)

• Drug Name: Indacaterol Drug Info
• Synonyms: 312753-06-3; QAB149; Arcapta; Onbrez; QAB-149; QAB 149; UNII-8OR09251MQ; 753498-25-8; CHEMBL1095777; CHEBI:68575; 8OR09251MQ; (R)-5-(2-(5,6-diethyl-2,3-dihydro-1H-inden-2-ylamino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one; 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one; Indacaterol Maleic Acid Salt; Indacaterol (USAN/INN); Indacaterol [USAN:INN:BAN]; 5-{(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl}-8-hydroxyquinolin-2(1H)-one; QAB-149; 5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one; Indacaterol/mometasone

Indication

Disease Entry	ICD 11	Status	REF
Chronic obstructive pulmonary disease	CA22	Approved	[1]
Asthma	CA23	Phase 4	[2]

• Cross-matching ID:
  PubChem CID: 6918554
  ChEBI ID: CHEBI:68575
  CAS Number: 312753-06-3
  TTD ID: D03DJL
  VARIDT ID: DR00064
  INTEDE ID: DR0867
  ACDINA ID: D00326

Full List of Drug Formulations Containing This Drug

Indacaterol 0.075 mg powder

Company	Formulation ID	FDA Description
Novartis Pharmaceuticals Corporation; Sunovion Pharmaceuticals	F10568	Lactose monohydrate

Indacaterol Maleate eq 75mcg base powder

Company	Formulation ID	FDA Description
Novartis	F23346	Lactose Monohydrate (Contains Trace Levels Of Milk Protein)

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7455).
• [2] ClinicalTrials.gov (NCT00442351) Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED). U.S. National Institutes of Health.